[Clinical effectiveness of newborn screening for inborn errors of metabolism. Part II: Methylmalonic acidemia, Propionic acidemia, Tyrosinemia type I]
Seoane Mato D, Cantero Muñoz P, Atienza Merino G
Record ID 32013000850
Spanish
Authors' objectives:
To assess the clinical effectiveness of newborn screening of the following diseases, i.e., methylmalonic acidemia, propionic acidemia and tyrosinaemia type 1.
Authors' recommendations:
The evidence of the effectiveness of screening programmes of inborn errors of metabolism evaluated in this review is of low quality and is based on observational studies – fundamentally longitudinal or comparative case series and cross-sectional studies without a control group – with direct evidence being furnished in only some cases.
Details
Project Status:
Completed
Year Published:
2014
URL for published report:
http://www.sergas.es/docs/Avalia-t/avalia-t201402Cribado-ECM-II.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Spain
MeSH Terms
- Humans
- Metabolism, Inborn Errors
- Neonatal Screening
Contact
Organisation Name:
Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
Contact Address:
Conselleria de Sanidade, Xunta de Galicia, San Lazaro s/n 15781 Santiago de Compostela, Spain. Tel: 34 981 541831; Fax: 34 981 542854;
Contact Name:
avalia-t@sergas.es
Contact Email:
avalia-t@sergas.es
Copyright:
Galician Agency for Health Technology Assessment (AVALIA-T)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.